PMN
ProMIS Neurosciences Inc.
9.10$
-1.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -71.7% | +572.5% | +414.9% | -60.6% | -13.6% | -7.0% | +434,587.6% | -100.0% | +115.9% | – | |
| – | – | – | – | -323.5% | – | – | +178.1% | -78.1% | +11.1% | -394.7% | – | – | |
| – | – | – | -100.0% | – | +5.8% | +4.2% | -100.0% | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -100.7% | – | -100.0% | -100.0% | – | – | -101.3% | – | -100.0% | – | |
| – | – | – | – | – | -140.1% | – | – | – | -185.2% | – | -118.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.